| Year | Firm | Client | Income | Doc |
|---|---|---|---|---|
| 2026 2nd Quarter - Report |
TARPLIN, DOWNS & YOUNG, LLC | BREAKTHROUGH T1D (FKA JUVENILE DIABETES RESEARCH… | $80,000 | |
| 2026 2nd Quarter - Report |
TARPLIN, DOWNS & YOUNG, LLC | BIOTECHNOLOGY INDUSTRY ORGANIZATION | $80,000 | |
| 2026 2nd Quarter - Report |
TARPLIN, DOWNS & YOUNG, LLC | MERCK | $50,000 | |
| 2026 2nd Quarter - Report |
TARPLIN, DOWNS & YOUNG, LLC | GILEAD SCIENCES, INC. | $80,000 | |
| 2026 2nd Quarter - Report |
TARPLIN, DOWNS & YOUNG, LLC | SAS | $80,000 | |
| 2026 2nd Quarter - Report |
TARPLIN, DOWNS & YOUNG, LLC | FLAGSHIP PIONEERING | $80,000 | |
| 2026 2nd Quarter - Report |
TARPLIN, DOWNS & YOUNG, LLC | ALZHEIMER'S ASSOCIATION | $80,000 | |
| 2026 2nd Quarter - Report |
TARPLIN, DOWNS & YOUNG, LLC | SANOFI US SERVICES INC (FORMERLY KNOWN AS GENZYME… | $60,000 | |
| 2026 2nd Quarter - Report |
TARPLIN, DOWNS & YOUNG, LLC | NEUROCRINE BIOSCIENCES, INC. | $110,000 | |
| 2026 2nd Quarter - Report |
TARPLIN, DOWNS & YOUNG, LLC | HANSA BIOPHARMA | $60,000 |